147 related articles for article (PubMed ID: 8116074)
21. Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis and treatment of unknown primary tumors].
Dodion P; De Valeriola D
Bull Cancer; 1989; 76(9):939-46. PubMed ID: 2695183
[TBL] [Abstract][Full Text] [Related]
23. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic value of bone marrow biopsy for bone marrow metastatic tumor with unknown primary tumor site].
Wu Y; Yao LQ; Cheng J; Tian H
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1069-71. PubMed ID: 20501396
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological characteristics of distant metastases of adenocarcinoma, squamous cell carcinoma and urothelial carcinoma: An autopsy study of older Japanese patients.
Matsuda Y; Seki A; Nonaka K; Kakizaki M; Wang T; Aida J; Ishikawa N; Nakano Y; Kaneda D; Takata T; Takahashi-Fujigasaki J; Murayama S; Takubo K; Ishiwata T; Sawabe M; Arai T
Geriatr Gerontol Int; 2018 Feb; 18(2):211-215. PubMed ID: 28914998
[TBL] [Abstract][Full Text] [Related]
26. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic approach to cancer of unknown primary site].
Fernández Cotarelo MJ; Guerra Vales JM
Rev Clin Esp; 2009; 209(7):347-51. PubMed ID: 19709540
[TBL] [Abstract][Full Text] [Related]
28. Pathologic evaluation of unknown primary cancer.
Oien KA
Semin Oncol; 2009 Feb; 36(1):8-37. PubMed ID: 19179185
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological characterization and autopsybased classification of the Cancer of Unknown Primary origin (CUP) syndrome].
Kocsmár É; Kocsmár I; Karczub J; Istók R; Kiss A; Schaff Z; Lotz G
Magy Onkol; 2019 Jun; 63(2):75-84. PubMed ID: 31225530
[TBL] [Abstract][Full Text] [Related]
30. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
32. Hepatic metastases from carcinomas of unknown primary site.
Pouessel D; Thezenas S; Culine S; Becht C; Senesse P; Ychou M
Gastroenterol Clin Biol; 2005 Dec; 29(12):1224-32. PubMed ID: 16518276
[TBL] [Abstract][Full Text] [Related]
33. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
[TBL] [Abstract][Full Text] [Related]
34. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
35. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
36. Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?
Lawrenz JM; Gordon J; George J; Haben C; Rubin BP; Ilaslan H; Mesko NW; Nystrom LM
Clin Orthop Relat Res; 2020 Nov; 478(11):2451-2457. PubMed ID: 33112582
[TBL] [Abstract][Full Text] [Related]
37. Malignant ascites of unknown origin.
Ringenberg QS; Doll DC; Loy TS; Yarbro JW
Cancer; 1989 Aug; 64(3):753-5. PubMed ID: 2743267
[TBL] [Abstract][Full Text] [Related]
38. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
Kirsten F; Chi CH; Leary JA; Ng AB; Hedley DW; Tattersall MH
Q J Med; 1987 Feb; 62(238):143-61. PubMed ID: 3659256
[TBL] [Abstract][Full Text] [Related]
39. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
40. Metastatic vs primary malignant neoplasms affecting the umbilicus: clinicopathologic features of 77 tumors.
Papalas JA; Selim MA
Ann Diagn Pathol; 2011 Aug; 15(4):237-42. PubMed ID: 21419680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
